China Securities Co.Ltd(601066)
about
Tinavi Medical Technologies Co.Ltd(688277) issue shares to specific objects in 2021
And listed on the scientific innovation board
of
Issuance recommendation
Sponsor
May, 2002
Statement of recommendation institution and recommendation representative
China Securities Co.Ltd(601066) and the project’s sponsor representatives sun Dong and Zhu Jin, in accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China and other relevant laws and regulations, the relevant provisions of the China Securities Regulatory Commission and the relevant business rules of Shanghai Stock Exchange, are honest, trustworthy, diligent and responsible, and issue this issuance recommendation letter in strict accordance with the business rules, industrial practice norms and ethical standards formulated according to law, And ensure the authenticity, accuracy and completeness of the issuance recommendation letter.
catalogue
interpretation…… Section 1 basic information of this securities issuance 5 I. The sponsor representative specifically responsible for the recommendation of this securities issuance 5 II. The co sponsors of this securities issuance project and other members of the project team 5 III. basic information of the issuer 6 IV. description of the relationship between the sponsor and the issuer 10 v. internal audit procedures and core opinions of the recommendation institution Vi. verification of private investment fund filing by the sponsor Section 2 commitments of the sponsor 14 section III verification of relevant behaviors such as paid employment of third-party institutions and individuals 15 I. verification of the sponsor’s paid employment of a third party and other related acts 15 II. Verification of the issuer’s paid employment of a third party and other related acts 15 Section IV recommendations for this offering 16 I. the decision-making procedure of the Issuer on this issuance is legal 16 II. This offering complies with relevant laws and regulations 17 III. main risk tips of the issuer 21 IV. evaluation of the development prospect of the issuer 28 v. recommendation conclusion of the recommendation institution on this securities issuance twenty-eight
interpretation
Unless otherwise specified in this letter, the words sponsor and underwriter refer to the following sponsors and actual underwriters and underwriters in the company
Company Law refers to the company law of the people’s Republic of China
Securities Law refers to the securities law of the people’s Republic of China
General meeting of shareholders refers to Tinavi Medical Technologies Co.Ltd(688277) general meeting of shareholders
Board of directors means Tinavi Medical Technologies Co.Ltd(688277) board of directors
Board of supervisors refers to Tinavi Medical Technologies Co.Ltd(688277) board of supervisors
CSRC refers to the China Securities Regulatory Commission
Shanghai stock exchange refers to Shanghai Stock Exchange
This securities issuance and this issuance refer to the issuance of shares to specific objects in Tinavi Medical Technologies Co.Ltd(688277) 2021
A shares and shares refer to the RMB ordinary shares with a par value of RMB 1.00 per share issued by the company
Yuan refers to RMB yuan (except specifically referred to herein)
Pricing base date refers to the base date for calculating the issue reserve price
The State Drug Administration and nmpa refer to the State Drug Administration
The state health and family planning commission refers to the state health and Family Planning Commission of the people’s Republic of China
The measures for the administration of the registration of the science and Innovation Board refer to the measures for the administration of the registration of securities issuance of listed companies on the science and Innovation Board (Trial)
(row)
Mazor robotics refers to mazor robotics Ltd., an Israeli orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) manufacturer, which was later acquired by Medtronic
Mako surgical company refers to Mako surgical Corp., a joint replacement Siasun Robot&Automation Co.Ltd(300024) manufacturer in the United States, which was later acquired by Stryker
MedTech company refers to MedTech S.A.S, a French surgery Siasun Robot&Automation Co.Ltd(300024) manufacturing enterprise, which was later acquired by Gemini bangmei
Medtronic, founded in 1949 and headquartered in the United States, is one of the largest medical technology companies in the world. It mainly provides lifelong treatment solutions for patients with chronic diseases. It governs cardiovascular business group, restorative therapy business group Minimally invasive treatment business group and diabetes business group.
Stryker Corporation, founded in 1946 and headquartered in the United States, is one of the largest orthopaedic and medical technology companies in the world, with 14 production, R & D and sales divisions around the world
Zimmer Biomet, founded in 1927 and headquartered in the United States, is committed to the design, R & D, manufacturing and marketing of orthopaedic reconstruction, spinal cord and trauma instruments, artificial dental implants and related surgical products
Xinjun refers to Shenzhen xinjunte intelligent medical device Co., Ltd
Any discrepancy between the total number and the mantissa of the sum of the itemized values in this issuance recommendation letter shall be caused by rounding.
Section 1 basic information of this securities issuance
1、 The sponsor representative specifically responsible for the recommendation of this securities issuance
China Securities Co.Ltd(601066) securities appoints sun Dong and Zhu Jin as the sponsor representatives of this offering to specific objects.
The practice of the above two sponsor representatives is as follows:
Mr. Sun Dong: sponsor representative, master’s degree, now the director of China Securities Co.Ltd(601066) securities investment banking business management committee. The projects that have hosted or participated in have included: Hongda Xingye Co.Ltd(002002) 852 theprojects that have presidepresidepresidepresidepresidepresidepresideor or participated in or the projects that have hosted or participated in: the initial public offering of the ‘ Hongda Xingye Co.Ltd(002002) Shanghai Lisheng Racing Co.Ltd(002858) 5852 of the convertiblebond project, Sany Heavy Industry Co.Ltd(600031) M & a project, guochuang energy M & a project Zhuzhou Tianqiao Crane Co.Ltd(002523) M & a project, CRRC industrial investment M & a project, etc. During the practice of recommendation business, we strictly abide by the measures for the administration of securities issuance and listing recommendation business and other relevant provisions, and have a good practice record.
Mr. Zhu Jin: sponsor representative, master’s degree, now vice president of China Securities Co.Ltd(601066) securities investment banking business management committee. He has presided over or participated in: Daodaoquan Grain And Oil Co.Ltd(002852) initial public offering project, Tinavi Medical Technologies Co.Ltd(688277) initial public offering project, Liyuan refining non-public offering project, Hbis Company Limited(000709) share allotment project, Talkweb Information System Co.Ltd(002261) non-public offering project, Ja Solar Technology Co.Ltd(002459) non-public offering project, Tianye Tonglian merger and reorganization project, Shandong Ruifeng Chemical Co.Ltd(300243) merger and reorganization project, etc. During the practice of recommendation business, we strictly abide by the measures for the administration of securities issuance and listing recommendation business and other relevant provisions, and have a good practice record. 2、 Co sponsors of this securities issuance project and other members of the project team (I) Co sponsors of this securities issuance project
The co sponsor of this securities issuance project is Li Jihua, and the implementation of its recommendation business is as follows:
Mr. Li Jihua: with a master’s degree, he is now the senior vice president of China Securities Co.Ltd(601066) securities investment banking business management committee. He has presided over or participated in: Daodaoquan Grain And Oil Co.Ltd(002852) initial public offering project, Sinosteel New Materials Co.Ltd(002057) non-public offering project, etc. During the practice of recommendation business, we strictly abide by the measures for the administration of securities issuance and listing recommendation business and other relevant provisions, and have a good practice record.
(II) other members of this project
Other members of the securities issuance project team include Song Yang, Chen Yue, Zhou Zhenxiang and Jin Huaqiang.
Mr. Song Yang: sponsor representative, master’s degree, now senior vice president of China Securities Co.Ltd(601066) securities investment banking department. The projects that have hosted or participated in the past include: Shenzhen Liande Automatic Equipment Co.Ltd(300545) \ convertible bonds, Unilumin Group Co.Ltd(300232) issuing shares to purchase assets Sany Heavy Industry Co.Ltd(600031) M & A projects and CRRC industrial investment M & A projects.
Mr. Chen Yue: sponsor representative, master’s degree, now vice president of China Securities Co.Ltd(601066) securities investment banking business management committee. He has presided over or participated in: Shenyang Machine Tool non-public offering project, China Railway Signal & Communication Corporation Limited(688009) H-share initial public offering project, Hengda new material initial public offering project, Baishan technology initial public offering project, Ningbo Shanshan Co.Ltd(600884) major asset restructuring project, Hunan Mendale Hometextile Co.Ltd(002397) non-public offering project, etc.
Mr. Zhou Zhenxiang: certified public accountant, master’s degree, now senior manager of China Securities Co.Ltd(601066) securities investment banking business management committee. He has presided over or participated in the following projects: China Railway Group Limited(601390) acquisition of the control right project of Beijing Hengtong innovation saimu Technology Co., Ltd. Sinotrans Limited(601598) share exchange, absorption and merger of air transport development and listing on the Shanghai Stock Exchange.
Mr. Jin Huaqiang: with a master’s degree, he is now the senior manager of China Securities Co.Ltd(601066) securities investment banking business management committee. Projects participated in include: Talkweb Information System Co.Ltd(002261) non-public offering project, CRRC mixed ownership reform project, Sany Heavy Industry Co.Ltd(600031) merger and reorganization project, Zhuzhou Tianqiao Crane Co.Ltd(002523) merger and reorganization project, Tinavi Medical Technologies Co.Ltd(688277) initial public offering project, etc. 3、 Basic information of the issuer (I) overview of the issuer
Company name: Tinavi Medical Technologies Co.Ltd(688277)
Registered address: room 206, floor 2, building 1, Dongsheng science and Technology Park, No. 66, xixiaokou Road, Haidian District, Beijing
Date of establishment: October 22, 2010
Listing time: July 7, 2020
Registered capital: 41984684800 yuan
Place of listing: Shanghai Stock Exchange
Stock abbreviation Tinavi Medical Technologies Co.Ltd(688277)
Stock Code: Tinavi Medical Technologies Co.Ltd(688277)
Legal representative: Zhang Songgen
Secretary of the board of directors: Huang Junhui
Tel.: 010821566608009
Internet address: https://cn.tinavi.com.
Main business: R & D, production, sales and service of Orthopaedic Surgery Siasun Robot&Automation Co.Ltd(300024)
Type of this securities issuance: issuing shares to specific objects and listing
(II) equity structure
As of April 30, 2022, the share capital structure of the issuer is as follows:
Number of share classes (shares) proportion (%)
1、 Tradable shares with limited sales conditions 12258126029.20
1. State Shareholding —
2. Shareholding of state-owned legal person —
3. Other domestic shares 12228126029.13
Including: shares held by domestic non-state-owned legal persons 4416306010.52
78118200 shares held by domestic natural persons
